190 related articles for article (PubMed ID: 12013540)
1. Incorporating human interindividual biotransformation variance in health risk assessment.
Lipscomb JC; Kedderis GL
Sci Total Environ; 2002 Apr; 288(1-2):13-21. PubMed ID: 12013540
[TBL] [Abstract][Full Text] [Related]
2. Application of in vitro biotransformation data and pharmacokinetic modeling to risk assessment.
Kedderis GL; Lipscomb JC
Toxicol Ind Health; 2001 Jun; 17(5-10):315-21. PubMed ID: 12539878
[TBL] [Abstract][Full Text] [Related]
3. Interindividual variance of cytochrome P450 forms in human hepatic microsomes: correlation of individual forms with xenobiotic metabolism and implications in risk assessment.
Snawder JE; Lipscomb JC
Regul Toxicol Pharmacol; 2000 Oct; 32(2):200-9. PubMed ID: 11067776
[TBL] [Abstract][Full Text] [Related]
4. Extrapolation of in vitro enzyme induction data to humans in vivo.
Kedderis GL
Chem Biol Interact; 1997 Nov; 107(1-2):109-21. PubMed ID: 9402953
[TBL] [Abstract][Full Text] [Related]
5. Human cytochrome P450 isozymes in metabolism and health effects of gasoline ethers.
Hong JY; Wang YY; Mohr SN; Bondoc FY; Deng C
Res Rep Health Eff Inst; 2001 May; (102):7-27; discussion 95-109. PubMed ID: 11504148
[TBL] [Abstract][Full Text] [Related]
6. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
Butler AM; Murray M
J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
[TBL] [Abstract][Full Text] [Related]
7. Overview of enzymes of drug metabolism.
Meyer UA
J Pharmacokinet Biopharm; 1996 Oct; 24(5):449-59. PubMed ID: 9131484
[TBL] [Abstract][Full Text] [Related]
8. The impact of cytochrome P450 2E1-dependent metabolic variance on a risk-relevant pharmacokinetic outcome in humans.
Lipscomb JC; Teuschler LK; Swartout J; Popken D; Cox T; Kedderis GL
Risk Anal; 2003 Dec; 23(6):1221-38. PubMed ID: 14641897
[TBL] [Abstract][Full Text] [Related]
9. Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane.
Kharasch ED; Thummel KE
Anesthesiology; 1993 Oct; 79(4):795-807. PubMed ID: 8214760
[TBL] [Abstract][Full Text] [Related]
10. Risk assessment: toxicity from chemical exposure resulting from enhanced expression of CYP2E1.
Raucy JL
Toxicology; 1995 Dec; 105(2-3):217-24. PubMed ID: 8571359
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of the xenobiotic-metabolizing Cytochrome P450 expression pattern in human lung tissue by immunochemical and activity determination.
Bernauer U; Heinrich-Hirsch B; Tönnies M; Peter-Matthias W; Gundert-Remy U
Toxicol Lett; 2006 Jul; 164(3):278-88. PubMed ID: 16483733
[TBL] [Abstract][Full Text] [Related]
12. In vitro to in vivo extrapolation for trichloroethylene metabolism in humans.
Lipscomb JC; Fisher JW; Confer PD; Byczkowski JZ
Toxicol Appl Pharmacol; 1998 Oct; 152(2):376-87. PubMed ID: 9853006
[TBL] [Abstract][Full Text] [Related]
13. Sudan I is a potential carcinogen for humans: evidence for its metabolic activation and detoxication by human recombinant cytochrome P450 1A1 and liver microsomes.
Stiborová M; Martínek V; Rýdlová H; Hodek P; Frei E
Cancer Res; 2002 Oct; 62(20):5678-84. PubMed ID: 12384524
[TBL] [Abstract][Full Text] [Related]
14. Human liver microsomal cytochrome P450 3A isozymes mediated vindesine biotransformation. Metabolic drug interactions.
Zhou XJ; Zhou-Pan XR; Gauthier T; Placidi M; Maurel P; Rahmani R
Biochem Pharmacol; 1993 Feb; 45(4):853-61. PubMed ID: 8452560
[TBL] [Abstract][Full Text] [Related]
15. Benzene metabolism by human liver microsomes in relation to cytochrome P450 2E1 activity.
Seaton MJ; Schlosser PM; Bond JA; Medinsky MA
Carcinogenesis; 1994 Sep; 15(9):1799-806. PubMed ID: 7923572
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial Biotransformation of Drugs and other Xenobiotics.
Orhan H; Karakuş F; Ergüç A
Curr Drug Metab; 2021; 22(8):657-669. PubMed ID: 34182906
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P-450 2B6 is responsible for interindividual variability of propofol hydroxylation by human liver microsomes.
Court MH; Duan SX; Hesse LM; Venkatakrishnan K; Greenblatt DJ
Anesthesiology; 2001 Jan; 94(1):110-9. PubMed ID: 11135730
[TBL] [Abstract][Full Text] [Related]
18. Assessment of enzyme induction and enzyme inhibition in humans: toxicological implications.
Park BK; Kitteringham NR
Xenobiotica; 1990 Nov; 20(11):1171-85. PubMed ID: 2275213
[TBL] [Abstract][Full Text] [Related]
19. Variability in aflatoxin B(1)-macromolecular binding and relationship to biotransformation enzyme expression in human prenatal and adult liver.
Doi AM; Patterson PE; Gallagher EP
Toxicol Appl Pharmacol; 2002 May; 181(1):48-59. PubMed ID: 12030842
[TBL] [Abstract][Full Text] [Related]
20. In vitro metabolism of terfenadine by a purified recombinant fusion protein containing cytochrome P4503A4 and NADPH-P450 reductase. Comparison to human liver microsomes and precision-cut liver tissue slices.
Rodrigues AD; Mulford DJ; Lee RD; Surber BW; Kukulka MJ; Ferrero JL; Thomas SB; Shet MS; Estabrook RW
Drug Metab Dispos; 1995 Jul; 23(7):765-75. PubMed ID: 7587966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
